Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.33 |
| ▸ | ADH1C | P00326 | 2/20 | 0.32 |
| ▸ | ADH1A | P07327 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MITF | O75030 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24435393 | 1.00 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1MEN1KMT2AHSD11B1 | |
| SCHEMBL24435397 | 1.00 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1MEN1KMT2AHSD11B1 | |
| SCHEMBL24435398 | 0.98 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1MEN1KMT2AHSD11B1 | |
| SCHEMBL24435395 | 0.96 | DPP4 (0.31) | ALDH1A1L3MBTL1 | |
| SCHEMBL24435390 | 0.91 | — | — | |
| SCHEMBL26211334 | 0.76 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL26211337 | 0.76 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL26211329 | 0.76 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL27786904 | 0.74 | MEN1 (0.33) | ALDH1A1L3MBTL1MEN1KMT2AHSD11B1 | |
| SCHEMBL26211327 | 0.73 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230277652-A1 | NUCLEIC ACID VACCINES FOR CORONAVIRUS | SUZHOU ABOGEN BIOSCIENCES CO LTD (CN) | 2023-09-07 | — | — | US | disclosed |
| US-20230277652-A1 | NUCLEIC ACID VACCINES FOR CORONAVIRUS | SUZHOU ABOGEN BIOSCIENCES CO LTD (CN) | 2023-09-07 | — | — | US | disclosed |
| US-11472766-B2 | Lipid nanoparticle composition | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2022-10-18 | — | — | US | disclosed |
| US-20220218816-A1 | NUCLEIC ACID VACCINES FOR CORONAVIRUS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2022-07-14 | — | — | US | disclosed |
| US-20220153686-A1 | LIPID NANOPARTICLE COMPOSITION | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277652-A1 | NUCLEIC ACID VACCINES FOR CORONAVIRUS | SARS1, POLRMT, SARNP | ALDH1A1 3743/4885L3MBTL1 823/4885MEN1 4458/4885 |
| US-20220153686-A1 | LIPID NANOPARTICLE COMPOSITION | CETP, NPC1, LCAT | ALDH1A1 4587/4885L3MBTL1 1165/4885MEN1 2081/4885 |
| US-11472766-B2 | Lipid nanoparticle composition | CETP, NPC1, LCAT | ALDH1A1 4587/4885L3MBTL1 1165/4885MEN1 2081/4885 |
| US-20220218816-A1 | NUCLEIC ACID VACCINES FOR CORONAVIRUS | SARS1, POLRMT, SARNP | ALDH1A1 3743/4885L3MBTL1 823/4885MEN1 4458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.